Table 1.

Cervical cytology results from screening tests in 2011 overall and by age

Age group
15–2021–2930–3940–4950–6566–8421–65
Test resultaN (%)N (%)N (%)N (%)N (%)N (%)N (%)
Negative6,099 (81.9)41,162 (87.1)39,021 (91.8)37,225 (93.5)50,113 (95.3)9,370 (95.4)167,521 (91.9)
ASC-US612 (8.2)3,314 (7.0)1,983 (4.7)1,676 (4.2)1,496 (2.8)194 (2.0)8,469 (4.6)
LSIL628 (8.4)2,018 (4.3)850 (2.0)415 (1.0)323 (0.6)44 (0.4)3,606 (2.0)
ASC-H42 (0.6)295 (0.6)177 (0.4)72 (0.2)100 (0.2)17 (0.2)644 (0.4)
HSIL24 (0.3)247 (0.5)147 (0.3)67 (0.2)43 (0.1)12 (0.1)504 (0.3)
SCC0 (0)1 (0.0)4 (0.0)2 (0.0)4 (0.0)2 (0.0)11 (0.0)
AGC3 (0.0)80 (0.2)126 (0.3)148 (0.4)160 (0.3)28 (0.3)514 (0.3)
AIS0 (0)2 (0.0)3 (0.0)1 (0.0)0 (0)0 (0)6 (0.0)
ADCA0 (0)2 (0.0)2 (0.0)4 (0.0)20 (0.0)10 (0.1)28 (0.0)
CA0 (0)1 (0.0)0 (0)1 (0.0)2 (0.0)2 (0.0)4 (0.0)
Insufficient/No Dx43 (0.6)157 (0.3)184 (0.4)219 (0.5)347 (0.7)143 (1.5)907 (0.5)
All7,451 (100.0)47,279 (100.0)42,497 (100.0)39,830 (100.0)52,608 (100.0)9,822 (100.0)182,214 (100.0)
ASC-US + LSIL1,240 (16.6)5,332 (11.3)2,833 (6.7)2,091 (5.2)1,819 (3.5)238 (2.4)12,075 (6.6)
ASC-H & HSIL+69 (0.9)628 (1.3)459 (1.1)295 (0.7)329 (0.6)71 (0.7)1,711 (0.9)

NOTE: Screening tests were performed at least 300 days after any previous cytology test.

  • aASC-US, atypical squamous cells of undetermined significance; ASC-H, atypical squamous cells cannot rule out HSIL; LSIL, low-grade grade squamous intraepithelial lesion; HSIL, high-grade squamous intraepithelial lesion; SCC, squamous cell carcinoma; AGC, atypical glandular cells; AIS, adenocarcinoma in situ; ADCA, adenocarcinoma; CA, carcinoma not otherwise specified; Insufficient/No Dx, insufficient sample for diagnostic test or no diagnosis provided.